07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CD4NY<br />

28334<br />

lymphocyte counts from HIV 1-infected patients: total lymphocyte count fluctuations and diurnal cycle<br />

are important. J AIDS 1990;3:144-151 7. Paglieroni TG, Holland PV: Circannual variation in<br />

lymphocyte subsets, revisited. Transfusion 1994;34:512-516 8. U.S. Department of Health and Human<br />

Services: Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and<br />

adolescents infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep<br />

1994;43:1-21 9. Shearer WT, Rosenblatt HM, Gelman RS, et al: Lymphocyte subsets in healthy<br />

children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 study. J<br />

Allergy Clin Immunol 2003 November;112(5):973-980<br />

CD4 Count for Monitoring, New York, Blood<br />

Clinical Information: The infection of and subsequent decrease in the number of T-cells expressing<br />

the CD4 receptor (T-helper cells) is the main pathogenic mechanism of HIV. Progressive depletion of<br />

CD4 T-cells is associated with an increased likelihood of AIDS and an unfavorable prognosis. The US<br />

Public Health Service recommends that CD4 levels be monitored every 3 to 6 months in all HIV-infected<br />

persons.(1)<br />

Useful For: Monitoring CD4 levels in HIV-infected patients<br />

Interpretation: When the CD4 count falls below 500 cells/mcL, HIV-positive patients can be<br />

diagnosed with AIDS and can receive antiretroviral therapy. When the CD4 count falls below 200<br />

cells/mcL, prophylaxis against Pneumocystis jiroveci (formerly carinii) pneumonia is recommended.<br />

Reference Values:<br />

T & B SURFACE MARKER<br />

% T cells (CD3)<br />

0-2 months: 53-84%*<br />

3-5 months: 51-77%*<br />

6-11 months: 49-76%*<br />

12-23 months: 53-75%*<br />

2-5 years: 56-75%*<br />

6-11 years: 60-76%*<br />

12-17 years: 56-84%*<br />

18-55 years: 59-83%<br />

>55 years: 49-87%<br />

% Helper cells (CD4)<br />

0-2 months: 35-64%*<br />

3-5 months: 35-56%*<br />

6-11 months: 31-56%*<br />

12-23 months: 32-51%*<br />

2-5 years: 28-47%*<br />

6-11 years: 31-47%*<br />

12-17 years: 31-52%*<br />

18-55 years: 31-59%<br />

>55 years: 32-67%<br />

% Suppressor cells (CD8)<br />

0-2 months: 12-28%*<br />

3-5 months: 12-23%*<br />

6-11 months: 12-24%*<br />

12-23 months: 14-30%*<br />

2-5 years: 16-30%*<br />

6-17 years: 18-35%*<br />

18-55 years: 12-38%<br />

>55 years: 8-40%<br />

ABSOLUTE COUNTS<br />

CD45 Lymph Count, Flow:<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 404

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!